Clinical trial
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation…
NCT00383890 · Hospira, now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00383890 |
|---|---|
| Title | A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation |
| Official title | A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Dexmedetomidine Used for Sedation During Elective Awake Fiberoptic Intubation |
| Lead sponsor | Hospira, now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Awake Fiberoptic Intubation |
| Intervention type | Drug |
| Interventions | Dexmedetomidine HCL Injection, Placebo |
| Enrollment | 124 |
| Start date | Aug 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Oct 4, 2006 |
| Last update posted | Jul 24, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: